Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

ABSTRACT The numerous functions of the liver are controlled primarily at the transcriptional level by the concerted actions of a limited number of hepatocyte-enriched transcription factors (hepatocyte nuclear factor 1α [HNF1α], -1β, -3α, -3β, -3γ, -4α, and -6 and members of the c/ebp family). Of these, only HNF4α (nuclear receptor 2A1) and HNF1α appear to be correlated with the differentiated phenotype of cultured hepatoma cells. HNF1α-null mice are viable, indicating that this factor is not an absolute requirement for the formation of an active hepatic parenchyma. In contrast, HNF4α-null mice die during embryogenesis. Moreover, recent in vitro experiments using tetraploid aggregation suggest that HNF4α is indispensable for hepatocyte differentiation. However, the function of HNF4α in the maintenance of hepatocyte differentiation and function is less well understood. To address the function of HNF4α in the mature hepatocyte, a conditional gene knockout was produced using the Cre-loxP system. Mice lacking hepatic HNF4α expression accumulated lipid in the liver and exhibited greatly reduced serum cholesterol and triglyceride levels and increased serum bile acid concentrations. The observed phenotypes may be explained by (i) a selective disruption of very-low-density lipoprotein secretion due to decreased expression of genes encoding apolipoprotein B and microsomal triglyceride transfer protein, (ii) an increase in hepatic cholesterol uptake due to increased expression of the major high-density lipoprotein receptor, scavenger receptor BI, and (iii) a decrease in bile acid uptake to the liver due to down-regulation of the major basolateral bile acid transporters sodium taurocholate cotransporter protein and organic anion transporter protein 1. These data indicate that HNF4α is central to the maintenance of hepatocyte differentiation and is a major in vivo regulator of genes involved in the control of lipid homeostasis.

[1]  J. Björkegren,et al.  A Deficiency of Microsomal Triglyceride Transfer Protein Reduces Apolipoprotein B Secretion* , 2000, The Journal of Biological Chemistry.

[2]  B. Viollet,et al.  Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4 , 1997, Molecular and cellular biology.

[3]  J. Chiang,et al.  Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. , 1998, Journal of lipid research.

[4]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Kardassis,et al.  Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. , 1992, The Journal of biological chemistry.

[6]  A. Fukamizu,et al.  Functional association between CBP and HNF4 in trans-activation. , 1997, Biochemical and biophysical research communications.

[7]  J. Auwerx,et al.  Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. , 1994, The Journal of biological chemistry.

[8]  M. Weiss,et al.  Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells , 1997, Molecular and cellular biology.

[9]  N. Daigle,et al.  Hepatocyte Nuclear Factor 3β (Foxa2) Is Dispensable for Maintaining the Differentiated State of the Adult Hepatocyte , 2000, Molecular and Cellular Biology.

[10]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[11]  D. Granner,et al.  SRC-1 and GRIP1 Coactivate Transcription with Hepatocyte Nuclear Factor 4* , 1998, The Journal of Biological Chemistry.

[12]  J. Peters,et al.  Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. , 1998, The Journal of biological chemistry.

[13]  I. Talianidis,et al.  Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. , 1994, Nucleic acids research.

[14]  Frances M. Sladek,et al.  Hepatocyte Nuclear Factor 4α , 2001 .

[15]  S. Duncan,et al.  Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. , 2000, Genes & development.

[16]  J. Darnell,et al.  The expression pattern of a Drosophila homolog to the mouse transcription factor HNF‐4 suggests a determinative role in gut formation. , 1993, The EMBO journal.

[17]  J. Bar-Tana,et al.  Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α , 1998, Nature.

[18]  J. Breslow,et al.  Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. , 1997, Journal of lipid research.

[19]  S. Malik,et al.  Control of Apolipoprotein AI Gene Expression through Synergistic Interactions between Hepatocyte Nuclear Factors 3 and 4* , 1996, The Journal of Biological Chemistry.

[20]  P. Meier,et al.  The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.

[21]  Carl Wu.  [14] Analysis of hypersensitive sites in chromatin , 1989 .

[22]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.

[23]  F. Sladek,et al.  The DNA Binding Domain of Hepatocyte Nuclear Factor 4 Mediates Cooperative, Specific Binding to DNA and Heterodimerization with the Retinoid X Receptor α* , 1997, The Journal of Biological Chemistry.

[24]  D. Kardassis,et al.  Cooperative Binding of Upstream Stimulatory Factor and Hepatic Nuclear Factor 4 Drives the Transcription of the Human Apolipoprotein A-II Gene* , 1999, The Journal of Biological Chemistry.

[25]  J. Björkegren,et al.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. , 1999, The Journal of clinical investigation.

[26]  D. Kardassis,et al.  Transactivation of the Human Apolipoprotein CII Promoter by Orphan and Ligand-dependent Nuclear Receptors , 1998, The Journal of Biological Chemistry.

[27]  C. Glueck,et al.  Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia. , 1987, Atherosclerosis.

[28]  S M Grundy,et al.  Dietary influences on serum lipids and lipoproteins. , 1990, Journal of lipid research.

[29]  F. Alt,et al.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Auwerx,et al.  Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. , 1990, Endocrinology.

[31]  D. Kardassis,et al.  A Short Proximal Promoter and the Distal Hepatic Control Region-1 (HCR-1) Contribute to the Liver Specificity of the Human Apolipoprotein C-II Gene , 1998, The Journal of Biological Chemistry.

[32]  J. Peters,et al.  Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific Manner* , 1998, The Journal of Biological Chemistry.

[33]  D. Moore,et al.  Hepatocyte nuclear factor-4 activates medium chain acyl-CoA dehydrogenase gene transcription by interacting with a complex regulatory element. , 1993, The Journal of biological chemistry.

[34]  J. Breslow,et al.  Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Wu.  Analysis of hypersensitive sites in chromatin. , 1989, Methods in enzymology.

[36]  P. Meier,et al.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.

[37]  Mark A. Magnuson,et al.  Hepatocyte-Specific Mutation Establishes Retinoid X Receptor α as a Heterodimeric Integrator of Multiple Physiological Processes in the Liver , 2000, Molecular and Cellular Biology.

[38]  C. Cladaras,et al.  Functional Domains of the Nuclear Receptor Hepatocyte Nuclear Factor 4* , 1997, The Journal of Biological Chemistry.

[39]  M. Bustin.  Preparation and application of immunological probes for nucleosomes. , 1989, Methods in enzymology.

[40]  A. Tedgui,et al.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.

[41]  J. Auwerx,et al.  Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. , 1995, The Journal of clinical investigation.

[42]  Johnm . Taylor,et al.  Structure of the Hepatic Control Region of the Human Apolipoprotein E/C-I Gene Locus (*) , 1995, The Journal of Biological Chemistry.

[43]  J. Ward,et al.  Regulation of the Liver Fatty Acid-binding Protein Gene by Hepatocyte Nuclear Factor 1α (HNF1α) ALTERATIONS IN FATTY ACID HOMEOSTASIS INHNF1α-DEFICIENT MICE , 2000 .

[44]  G. Ginsburg,et al.  Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells , 1992, Molecular and cellular biology.

[45]  F. Sladek,et al.  Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. , 1993, The Journal of biological chemistry.

[46]  Gavin Kelsey,et al.  Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis , 1994, Mechanisms of Development.

[47]  S. Cereghini.  Liver‐enriched transcription factors and hepatocyte differentiation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  F. Gonzalez,et al.  Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.

[49]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[50]  S. Karathanasis,et al.  TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4 , 1996, Molecular and cellular biology.

[51]  H. Brewer,et al.  Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo. , 2000, Journal of lipid research.

[52]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[53]  C. Winrow,et al.  Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4. , 1994, Gene expression.

[54]  I. Talianidis,et al.  Acetylation regulates transcription factor activity at multiple levels. , 2000, Molecular cell.

[55]  D. Moore,et al.  A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs , 1994, Molecular and cellular biology.

[56]  J. Auwerx,et al.  Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm (*) , 1996, The Journal of Biological Chemistry.

[57]  J. Darnell,et al.  Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. , 1990, Genes & development.

[58]  G. Crabtree,et al.  A transcriptional hierarchy involved in mammalian cell-type specification , 1992, Nature.

[59]  M. Tulliez,et al.  Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. , 1994, The Journal of biological chemistry.

[60]  B. Chang,et al.  Liver-specific Inactivation of the Abetalipoproteinemia Gene Completely Abrogates Very Low Density Lipoprotein/Low Density Lipoprotein Production in a Viable Conditional Knockout Mouse* , 1999, The Journal of Biological Chemistry.

[61]  H. Jamil,et al.  Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. , 1994, The Journal of biological chemistry.

[62]  Hao Li,et al.  Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. , 1994, The Journal of biological chemistry.

[63]  J. Chiang,et al.  HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). , 2000, Journal of lipid research.

[64]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[65]  P. A. Wood,et al.  Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression , 1996, Molecular and cellular biology.

[66]  I. Talianidis,et al.  Activation of CAAT Enhancer-binding Protein δ (C/EBPδ) by Interleukin-1 Negatively Influences Apolipoprotein C-III Expression* , 1997, The Journal of Biological Chemistry.

[67]  J. Ward,et al.  Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice. , 2000, The Journal of biological chemistry.

[68]  T. Osumi,et al.  Functional interactions between nuclear receptors recognizing a common sequence element, the direct repeat motif spaced by one nucleotide (DR-1). , 1998, Journal of biochemistry.

[69]  F. Hegardt,et al.  The hepatocyte nuclear factor 4 (HNF-4) represses the mitochondrial HMG-CoA synthase gene. , 1998, Biochemical and biophysical research communications.

[70]  K. Omori,et al.  The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers. , 1997, Biochimica et biophysica acta.

[71]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[72]  F. Sladek,et al.  Modulation of Transcriptional Activation and Coactivator Interaction by a Splicing Variation in the F Domain of Nuclear Receptor Hepatocyte Nuclear Factor 4α1 , 1999, Molecular and Cellular Biology.

[73]  M. Hadzopoulou-Cladaras,et al.  CREB-binding Protein Is a Transcriptional Coactivator for Hepatocyte Nuclear Factor-4 and Enhances Apolipoprotein Gene Expression* , 1999, The Journal of Biological Chemistry.